RecruitingNCT03320304
Long-term study of vagus nerve stimulation for hard-to-treat depression
About this title
Read the official source — NCT03320304Observational studyAges 18+Multiple countries
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- Vienna and 17 more locationsSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 14, 2017
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 500
- Sponsor
- LivaNova
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- United Kingdom, Belgium, Austria, ...
- Age range
- Over 18 Years
- Official registry ID
- NCT03320304
- Official title
Show the full official title
A Global PRospective, Multi-cEnter, ObServational Post-markeT Study tO Assess shoRt, Mid and Long-term Effectiveness and Efficiency of VNS Therapy® as Adjunctive Therapy in reaL-world patIents With diFficult to Treat dEpression.
Recruitment & locations
RecruitingVienna, Austria · Leuven, Belgium · Bamberg, Germany
15 more locations
- Bonn, Germany
- Cologne, Germany
- Essen, Germany
- Frankfurt, Germany
- Freiburg im Breisgau, Germany
- Göttingen, Germany
- Hanover, Germany
- Jena, Germany
- Leipzig, Germany
- Münster, Germany
- Wilhelmshaven, Germany
- Leicester, United Kingdom
- London, United Kingdom
- Newcastle upon Tyne, United Kingdom
- Wells, United Kingdom
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is LivaNova.
Who can participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
